Skip to contentS
Surgery Partners, Inc.
S
SGRYSurgery Partners, Inc. Q2 2022 · 10-Q
Revenue$615.40M$615.40M+13.3% vs Q2 2021 Net Income-$18.40M-$18.40MN/M vs Q2 2021 EPS Diluted-$0.21-$0.21N/M vs Q2 2021 Operating Income$76,500,000+28.6% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Surgery Partners, Inc. · CIK 1638833 · Engraved from SEC EDGAR
derived
Free Cash Flowderived$19,700,000N/M Margins · derivedOperating margin12.4%+1.5 pt vs Q2 2021
Net margin-3.0%+2.0 pt vs Q2 2021
ended Jun 30, 2022 · filed Aug 2, 2022 · 33 d after period end